61 related articles for article (PubMed ID: 1617673)
1. Distribution of the glucose transporters in human brain tumors.
Nishioka T; Oda Y; Seino Y; Yamamoto T; Inagaki N; Yano H; Imura H; Shigemoto R; Kikuchi H
Cancer Res; 1992 Jul; 52(14):3972-9. PubMed ID: 1617673
[TBL] [Abstract][Full Text] [Related]
2. Comparing 2 crystal structures and 12 AlphaFold2-predicted human membrane glucose transporters and their water-soluble glutamine, threonine and tyrosine variants.
Smorodina E; Tao F; Qing R; Jin D; Yang S; Zhang S
QRB Discov; 2022; 3():e5. PubMed ID: 37529287
[TBL] [Abstract][Full Text] [Related]
3. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
4. Importance of GLUT Transporters in Disease Diagnosis and Treatment.
Ismail A; Tanasova M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955833
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
6. Connexins in Cancer: Jekyll or Hyde?
Mulkearns-Hubert EE; Reizes O; Lathia JD
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33321749
[TBL] [Abstract][Full Text] [Related]
7. Expression of GLUT3 and HIF-1
Mei T; Wang Z; Wu J; Liu X; Tao W; Wang S; Chen F
Biomed Res Int; 2020; 2020():1682352. PubMed ID: 32908869
[TBL] [Abstract][Full Text] [Related]
8. Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells.
Tilekar K; Upadhyay N; Schweipert M; Hess JD; Macias LH; Mrowka P; Meyer-Almes FJ; Aguilera RJ; Iancu CV; Choe JY; Ramaa CS
Eur J Pharm Sci; 2020 Nov; 154():105512. PubMed ID: 32801003
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.
Tsurubuchi T; Shirakawa M; Kurosawa W; Matsumoto K; Ubagai R; Umishio H; Suga Y; Yamazaki J; Arakawa A; Maruyama Y; Seki T; Shibui Y; Yoshida F; Zaboronok A; Suzuki M; Sakurai Y; Tanaka H; Nakai K; Ishikawa E; Matsumura A
Cells; 2020 May; 9(5):. PubMed ID: 32455737
[TBL] [Abstract][Full Text] [Related]
10. A New Pathway Promotes Adaptation of Human Glioblastoma Cells to Glucose Starvation.
Azzalin A; Brambilla F; Arbustini E; Basello K; Speciani A; Mauri P; Bezzi P; Magrassi L
Cells; 2020 May; 9(5):. PubMed ID: 32443613
[TBL] [Abstract][Full Text] [Related]
11. KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.
Li H; Lan J; Wang G; Guo K; Han C; Li X; Hu J; Cao Z; Luo X
J Exp Clin Cancer Res; 2020 Jan; 39(1):12. PubMed ID: 31931846
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of human parathyroid adenoma.
di Masi A; Leboffe L; Sodo A; Tabacco G; Cesareo R; Sbroscia M; Giovannoni I; Taffon C; Crucitti P; Longo F; Manfrini S; Ricci MA; Ascenzi P; Crescenzi A; Palermo A
Endocrine; 2020 Mar; 67(3):699-707. PubMed ID: 31786773
[TBL] [Abstract][Full Text] [Related]
13. GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets.
Guda MR; Labak CM; Omar SI; Asuthkar S; Airala S; Tuszynski J; Tsung AJ; Velpula KK
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31491891
[TBL] [Abstract][Full Text] [Related]
14. Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy.
Zambrano A; Molt M; Uribe E; Salas M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31324056
[TBL] [Abstract][Full Text] [Related]
15. Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target.
Almahmoud S; Wang X; Vennerstrom JL; Zhong HA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181707
[TBL] [Abstract][Full Text] [Related]
16. Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors.
Jung JH; Ahn BC
Brain Tumor Res Treat; 2018 Oct; 6(2):47-53. PubMed ID: 30381916
[TBL] [Abstract][Full Text] [Related]
17. Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.
Prabhu A; Kesarwani P; Kant S; Graham SF; Chinnaiyan P
Neuro Oncol; 2017 Nov; 19(12):1599-1606. PubMed ID: 28541485
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas.
Azzalin A; Nato G; Parmigiani E; Garello F; Buffo A; Magrassi L
Neoplasia; 2017 Apr; 19(4):364-373. PubMed ID: 28319810
[TBL] [Abstract][Full Text] [Related]
19. Implications of Resveratrol on Glucose Uptake and Metabolism.
León D; Uribe E; Zambrano A; Salas M
Molecules; 2017 Mar; 22(3):. PubMed ID: 28272357
[TBL] [Abstract][Full Text] [Related]
20. Oncogene-directed alterations in cancer cell metabolism.
Nagarajan A; Malvi P; Wajapeyee N
Trends Cancer; 2016 Jul; 2(7):365-377. PubMed ID: 27822561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
